279 related articles for article (PubMed ID: 27072353)
21. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Zoledronic Acid for Treatment of Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
Wang C
Am J Ther; 2017; 24(5):e544-e552. PubMed ID: 26938765
[TBL] [Abstract][Full Text] [Related]
23. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
[TBL] [Abstract][Full Text] [Related]
24. Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis.
Long G; Liu C; Liang T; Zhang Z; Qin Z; Zhan X
J Orthop Surg Res; 2023 Aug; 18(1):574. PubMed ID: 37543616
[TBL] [Abstract][Full Text] [Related]
25. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2012 May; 344():e3427. PubMed ID: 22619194
[TBL] [Abstract][Full Text] [Related]
26. Risk of non-vertebral fractures in men with type 2 diabetes: A systematic review and meta-analysis of cohort studies.
Gao Y; Chai F
Exp Gerontol; 2021 Jul; 150():111378. PubMed ID: 33905874
[TBL] [Abstract][Full Text] [Related]
27. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
Weaver CM; Alexander DD; Boushey CJ; Dawson-Hughes B; Lappe JM; LeBoff MS; Liu S; Looker AC; Wallace TC; Wang DD
Osteoporos Int; 2016 Jan; 27(1):367-76. PubMed ID: 26510847
[TBL] [Abstract][Full Text] [Related]
28. Validation of a 5-year risk score of hip fracture in postmenopausal women. The Danish Nurse Cohort Study.
Hundrup YA; Jacobsen RK; Andreasen AH; Davidsen M; Obel EB; Abrahamsen B
Osteoporos Int; 2010 Dec; 21(12):2135-42. PubMed ID: 20157806
[TBL] [Abstract][Full Text] [Related]
29. Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study.
Hung YC; Lin CC; Chen HJ; Chang MP; Huang KC; Chen YH; Chen CC
Osteoporos Int; 2017 Jul; 28(7):2053-2060. PubMed ID: 28374044
[TBL] [Abstract][Full Text] [Related]
30. Parity and risk of hip fracture in postmenopausal women.
Kauppi M; Heliövaara M; Impivaara O; Knekt P; Jula A
Osteoporos Int; 2011 Jun; 22(6):1765-71. PubMed ID: 20924749
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of hip fractures in Korean patients with type 2 diabetes: a 6-year nationwide population-based study.
Kim SH; Kim YM; Yoo JS; Choe EY; Kim TH; Won YJ
J Bone Miner Metab; 2017 Nov; 35(6):623-629. PubMed ID: 27873075
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological characteristics and outcome in elderly patients sustaining non-simultaneous bilateral hip fracture: a systematic review and meta-analysis.
Zhu Y; Chen W; Sun T; Zhang Q; Liu S; Zhang Y
Geriatr Gerontol Int; 2015 Jan; 15(1):11-8. PubMed ID: 25363019
[TBL] [Abstract][Full Text] [Related]
33. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.
Cranney A; Wells G; Willan A; Griffith L; Zytaruk N; Robinson V; Black D; Adachi J; Shea B; Tugwell P; Guyatt G;
Endocr Rev; 2002 Aug; 23(4):508-16. PubMed ID: 12202465
[TBL] [Abstract][Full Text] [Related]
34. Abdominal aortic calcification and risk of fracture among older women - The SOF study.
Szulc P; Blackwell T; Kiel DP; Schousboe JT; Cauley J; Hillier T; Hochberg M; Rodondi N; Taylor BC; Black D; Cummings S; Ensrud KE;
Bone; 2015 Dec; 81():16-23. PubMed ID: 26115911
[TBL] [Abstract][Full Text] [Related]
35. Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools.
Bonaccorsi G; Messina C; Cervellati C; Maietti E; Medini M; Rossini M; Massari L; Greco P
Gynecol Endocrinol; 2018 May; 34(5):404-408. PubMed ID: 29172781
[TBL] [Abstract][Full Text] [Related]
36. A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women.
Mirzaei A; Jahed SA; Nojomi M; Rajaei A; Zabihiyeganeh M
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):389-393. PubMed ID: 29880171
[TBL] [Abstract][Full Text] [Related]
37. Secondary confounders of osteoporotic hip fractures in patients admitted to a geriatric acute care department.
Dovjak P; Föger-Samwald U; Konrad M; Bichler B; Pietschmann P
Z Gerontol Geriatr; 2015 Oct; 48(7):633-40. PubMed ID: 25421255
[TBL] [Abstract][Full Text] [Related]
38. Discriminative capacity of calcaneal quantitative ultrasound and of osteoporosis and fracture risk factors in postmenopausal women with osteoporotic fractures.
Hernández JL; Marin F; González-Macías J; Díez-Pérez A; Vila J; Giménez S; Galán B; Arenas MS; Suárez F; Gayola L; Guillén G; Sagredo T; Belenguer R; Moron A; Arriaza E;
Calcif Tissue Int; 2004 Apr; 74(4):357-65. PubMed ID: 15255073
[TBL] [Abstract][Full Text] [Related]
39. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
Jackson RD; Mysiw WJ
Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
[TBL] [Abstract][Full Text] [Related]
40. Non-hip and non-vertebral fractures: the neglected fracture sites.
Holloway KL; Henry MJ; Brennan-Olsen SL; Bucki-Smith G; Nicholson GC; Korn S; Sanders KM; Pasco JA; Kotowicz MA
Osteoporos Int; 2016 Mar; 27(3):905-913. PubMed ID: 26438309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
